Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 89,000 | -1,455,000 | -1,808,000 | 1,538,000 | 5,364,000 |
| Depreciation Amortization | 1,480,000 | 1,053,000 | 698,000 | 349,000 | 1,404,000 |
| Income taxes - deferred | -214,000 | -12,000 | 109,000 | 56,000 | -2,098,000 |
| Accounts receivable | -1,171,000 | -334,000 | 368,000 | -376,000 | -218,000 |
| Accounts payable and accrued liabilities | 80,000 | -134,000 | -113,000 | -109,000 | -61,000 |
| Other Working Capital | -1,638,000 | -864,000 | -139,000 | -1,101,000 | -798,000 |
| Other Operating Activity | 9,542,000 | 7,998,000 | 4,887,000 | 1,079,000 | 5,551,000 |
| Operating Cash Flow | $8,168,000 | $6,252,000 | $4,002,000 | $1,436,000 | $9,144,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 12,403,000 | 1,086,000 | -100,000 | -53,000 | -534,000 |
| PPE Investments | -650,000 | -469,000 | -314,000 | -171,000 | -825,000 |
| Net Acquisitions | -25,920,000 | -5,804,000 | -4,804,000 | -63,000 | -4,251,000 |
| Purchase Of Investment | -455,000 | -388,000 | -86,000 | -8,000 | -1,773,000 |
| Other Investing Activity | 7,000 | -63,000 | -63,000 | -49,000 | -434,000 |
| Investing Cash Flow | $-14,615,000 | $-5,638,000 | $-5,367,000 | $-344,000 | $-7,817,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 8,184,000 | 7,189,000 | N/A | N/A | N/A |
| Debt Repayment | -2,500,000 | -2,500,000 | -500,000 | -500,000 | -2,750,000 |
| Common Stock Issued | 256,000 | 248,000 | 212,000 | 177,000 | 209,000 |
| Common Stock Repurchased | -1,583,000 | -1,583,000 | -1,382,000 | -1,328,000 | -1,749,000 |
| Dividend Paid | -3,449,000 | -2,591,000 | -1,730,000 | -874,000 | -3,222,000 |
| Other Financing Activity | -138,000 | -124,000 | -85,000 | -86,000 | -122,000 |
| Financing Cash Flow | $770,000 | $639,000 | $-3,485,000 | $-2,611,000 | $-7,634,000 |
| Exchange Rate Effect | 43,000 | 2,000 | -35,000 | -61,000 | -2,000 |
| Beginning Cash Position | 11,631,000 | 11,631,000 | 11,631,000 | 11,631,000 | 17,940,000 |
| End Cash Position | 5,997,000 | 12,886,000 | 6,746,000 | 10,051,000 | 11,631,000 |
| Net Cash Flow | $-5,634,000 | $1,255,000 | $-4,885,000 | $-1,580,000 | $-6,309,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,168,000 | 6,252,000 | 4,002,000 | 1,436,000 | 9,144,000 |
| Capital Expenditure | -650,000 | -469,000 | -314,000 | -171,000 | -825,000 |
| Free Cash Flow | 7,518,000 | 5,783,000 | 3,688,000 | 1,265,000 | 8,319,000 |